{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:04:35Z","timestamp":1774893875179,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijid.2025.108166","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:02:28Z","timestamp":1762012948000},"page":"108166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["EXPRESS-PrEP: Evaluating PrEP rapid engagement and same-day start for HIV prevention in gbMSM"],"prefix":"10.1016","volume":"162","author":[{"given":"Kevin","family":"Woodward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Guimond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hommood","family":"Alrowais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Monroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Gemmell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108166_bib0001","series-title":"HIV in Canada: 2023 surveillance highlights \u2013 infographic","year":"2025"},{"key":"10.1016\/j.ijid.2025.108166_bib0002","series-title":"The Epidemiology of HIV in Canada","year":"2025"},{"key":"10.1016\/j.ijid.2025.108166_bib0003","series-title":"2024 Global AIDS Update","article-title":"HIV and Transgender People","year":"2024"},{"key":"10.1016\/j.ijid.2025.108166_bib0004","article-title":"Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of patterns, barriers, and facilitators","volume":"9","author":"Tan","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.ijid.2025.108166_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/apc.2019.0189","article-title":"Health care provider barriers to HIV pre-exposure prophylaxis in the United States: a systematic review","volume":"34","author":"Pleuhs","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ijid.2025.108166_bib0006","series-title":"Canadian Association for HIV Research (CAHR) 2022 Abstracts","article-title":"PRIMP PrEP Cascade results: only a minority of healthcare encounters among PrEP-eligible gbMSM lead to PrEP initiation","author":"Pico-Espinosa","year":"2025"},{"key":"10.1016\/j.ijid.2025.108166_bib0007","series-title":"HIV diagnostic serology \u2013 Test information index","year":"2025"},{"key":"10.1016\/j.ijid.2025.108166_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ijid.2025.108166_bib0009","doi-asserted-by":"crossref","first-page":"ofz310","DOI":"10.1093\/ofid\/ofz310","article-title":"Same-day HIV pre-exposure prophylaxis (PrEP) initiation during drop-in sexually transmitted diseases clinic appointments is a highly acceptable, feasible, and safe model that engages individuals at risk for HIV into PrEP care","volume":"6","author":"Kamis","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.108166_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30256-3","article-title":"Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention","volume":"8","author":"Rowan","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijid.2025.108166_bib0011","unstructured":"Coleman M, Godwin D, Logan M, Peer A, Cornell D. Abstract 5803 \u2014 PrEP initiation in a Washington D.C. sexual health clinic and linkage to primary care. 2019. https:\/\/stacks.cdc.gov\/view\/cdc\/76678\/cdc_76678_DS1.pdf [accessed 10 July, 2025]."},{"key":"10.1016\/j.ijid.2025.108166_bib0012","series-title":"Descovy (emtricitabine\/tenofovir alafenamide) \u2013 Product monograph","year":"2022"},{"key":"10.1016\/j.ijid.2025.108166_bib0013","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","article-title":"Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomized, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial","volume":"396","author":"Mayer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108166_bib0014","series-title":"Health Canada approves APRETUDE for PrEP to reduce risk of sexually acquired HIV","year":"2025"},{"key":"10.1016\/j.ijid.2025.108166_bib0015","series-title":"Alinity s HIV Ag\/Ab Combo \u2013 approval letter (STN BL125679\/7)","year":"2020"},{"key":"10.1016\/j.ijid.2025.108166_bib0016","series-title":"Fundamentals of Biostatistics","first-page":"293","article-title":"Hypothesis testing: categorical data; estimation of sample size and power for comparing two binomial proportions","author":"Rosner","year":"2011"},{"key":"10.1016\/j.ijid.2025.108166_bib0017","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"issue":"5","key":"10.1016\/j.ijid.2025.108166_bib0018","first-page":"480","article-title":"Engaging United States Black communities in HIV pre-exposure prophylaxis: analysis of a PrEP engagement cascade","volume":"110","author":"Kwakwa","year":"2018","journal-title":"J Natl Med Assoc"},{"issue":"11","key":"10.1016\/j.ijid.2025.108166_bib0019","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/OLQ.0000000000000514","article-title":"Implementation of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men at a New England sexually transmitted diseases clinic","volume":"43","author":"Chan","year":"2016","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijid.2025.108166_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000002611","article-title":"Breaking inertia: movement along the PrEP cascade in a longitudinal US national cohort of sexual minority individuals at risk for HIV","volume":"86","author":"Mehrotra","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ijid.2025.108166_bib0021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09540121.2024.2437564","article-title":"Use of HIV pre-exposure prophylaxis among men who have sex with men: low uptake and retention despite high-risk indications","volume":"37","author":"Orser","year":"2025","journal-title":"AIDS Care"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:31:53Z","timestamp":1766406713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"alternative-id":["S1201971225003881"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108166","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EXPRESS-PrEP: Evaluating PrEP rapid engagement and same-day start for HIV prevention in gbMSM","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108166"}}